The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia

Journal of Vascular Surgery

Volumn 48, Issue 4, 2008, Pages 865-871

  Davies, Mark G ^a   Saad, Wael E ^a   Peden, Eric K ^a   Mohiuddin, Imran T ^a   Naoum, Joseph J ^a   Lumsden, Alan B ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ENDOVASCULAR SURGERY; FALSE ANEURYSM; FEMALE; FIBROMUSCULAR DYSPLASIA; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMATOMA; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INGUINAL REGION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY SIZE; LIPOPROTEIN BLOOD LEVEL; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLIC SYNDROME X; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RENAL ARTERY; RENOVASCULAR HYPERTENSION; RESTENOSIS; SMOKING; STENOSIS; STENT; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; FEMALE; FIBROMUSCULAR DYSPLASIA; HUMANS; MALE; MIDDLE AGED; RENAL ARTERY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 55149100261     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.05.030     Document Type: Article

References (28)

1. Safian R.D., and Textor S.C. Renal-artery stenosis. N Engl J Med 344 (2001) 431-442
2. Leadbetter W.F., and Burkland C.E. Hypertension in unilateral renal disease. J Urol 39 (1938) 611
3. Slovut D.P., and Olin J.W. Fibromuscular dysplasia. N Engl J Med 350 (2004) 1862-1871
4. Ekelund L., Gerlock J., Molin J., and Smith C. Roentgenologic appearance of fibromuscular dysplasia. Acta Radiol Diagn (Stockh) 19 (1978) 433-446
5. Goncharenko V., Gerlock A.J.J., Shaff M.I., and Hollifield J.W. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology 139 (1981) 45-51
6. Caps M.T., Perissinotto C., Zierler R.E., Polissar N.L., Bergelin R.O., and Tullis M.J. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98 (1998) 2866-2872
7. Fernando D., and Garasic J. Percutaneous Intervention for renovascular disease rationale and patient selection. Curr Opin Cardiol 19 (2004) 582-588
8. Yutan E., Glickerman D.J., Caps M.T., Hatsukami T., Harley J.D., Kohler T.R., et al. Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. J Vasc Surg 34 (2001) 685-693
9. Sivamurthy N., Suroweic S.M., Culakova E., Rhodes J.M., Lee D., Sternbach Y., et al. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis. J Vasc Surg 39 (2004) 565-574
10. Galaria I.I., Surowiec S.M., Rhodes J.M., Illig K.A., Shortell C.K., Sternbach Y., et al. Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann Vasc Surg 19 (2005) 218-228
11. Rundback J.H., Sacks D., Kent K.C., Cooper C., Jones C., Murphy T.P., et al. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 106 (2002) 1572-1585
12. Grundy S.M., Brewer H.B.J., Cleeman J.I., and Conference Participants. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
13. Birrer M., Do D.D., Mahler F., Triller J., and Baumgartner I. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg 23 (2002) 146-152
14. Sos T.A., Pickering T.G., Sniderman K., Saddekni S., Case D.B., Silane M.F., et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 309 (1983) 274-279
15. Surowiec S.M., Sivamurthy N., Rhodes J.M., Lee D.E., Waldman D.L., Green R.M., et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 17 (2003) 650-655
16. Davidson R.A., Barri Y., and Wilcox C.S. Predictors of cure of hypertension in fibromuscular renovascular disease. Am J Kidney Dis 28 (1996) 334-338
17. Bonelli F.S., McKusick M.A., Textor S.C., Kos P.B., Stanson A.W., Johnson C.M., et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients [see comment]. Mayo Clinic Proc 70 (1995) 1041-1052
18. Tegtmeyer C.J., Selby J.B., Harlwell G.D., Ayers C., and Tegtmeyer V. Results and complications of angioplasty in fibromuscular disease. Circulation 83 2 suppl (1991) I155-I161
19. Baert A.L., Wilms G., Amery A., Vermylen J., and Suy R. Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients. Cardiovasc Intervent Radiol 13 (1990) 22-28
20. Holden A., and Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg 38 (2003) 962-968
21. Holden A., Hill A., Jaff M.R., and Pilmore H. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int 70 (2006) 830-832
22. Edwards M.S., Corriere M.A., Craven T.E., Pan X.M., Rapp J.H., Pearce J.D., et al. Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg 46 (2007) 55-61
23. Kane G.C., Textor S.C., Schirger A., McKusick M.A., Stanson A., Vesna D., et al. Factors associated with restenosis in women following percutaneous renal artery revascularization for hypertension. Am J Hypertens 16 (2003) 252A-253A
24. Oertle M., Do D.D., Baumgartner I., Triller J., and Mahler F. Discrepancy of clinical and angiographic results in the follow-up of percutaneous transluminal renal angioplasty. Vasa 27 (1998) 154-157
25. Cutlip D.E., Chauhan M.S., Baim D.S., Ho K.K., Popma J.J., Carrozza J.P., et al. Clinical restenosis after coronary stenting: perspectives from multi-center clinical trials. J Am Coll Cardiol 40 (2002) 2082-2089
26. Pache J., Kastrati A., Mehilli J., Schuhlen H., Dotzer F., Hausleiter J., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 41 (2003) 1283-1288
27. Gilbert J., Raboud J., and Zinman B. Meta-analysis of he effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting. Diabetes Care 27 (2004) 990-994
28. Piatti P., DiMario C., Monti L.D., Fragasso G., Sgura F., Caumo A., et al. Association of insulin resistance, hyperlipidemia and impaired nitric oxide release with instent restenosis in patients undergoing coronary stenting. Circulation 108 (2003) 2074-2081